AzTrials
AzTrials

Tooth LossNCT04605016

Clinical Performance of Dentals Implants With Hydrophilic or Hydrophobic Surfaces

A study testing Hydrophilic surface implants and Hydrophobic surface implants in people with Tooth Loss, run by Universidade Federal de Goias at 1 site in Brazil.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The aim of the study is to compare longitudinally the clinical performance of dental implants with different surfaces placed in single tooth gaps at the posterior maxilla and mandible of adults. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Tooth Loss
What is being tested?
Hydrophilic surface implants and Hydrophobic surface implants
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
44 participants
Where
1 siteBrazil
Study dates
1 Apr 2021to 30 Dec 2023
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Present single or multiple intercalated untreated tooth gaps in the posterior region of the mandible or maxilla;
  • Agree to participate in the study by signing the informed consent form.

Who cannot join

  • Unavailability for participation or signs that they could not comply with the schedule of follow-up visits;
  • Presence of general and/or local contraindications that could prevent the surgical procedure for implant placement;
  • Presence of conditions that may interfere with the prognosis, such as current treatment with bisphosphonates or report of use for less than 2 years, presence of rheumatic diseases, among others;
  • Absence of the minimum bone quantity of 8 mm in length and 3.75 mm in diameter for installation of an implant in the tooth gap;
  • Absence of a mesio-distal space of at least 4.6 mm in the single tooth gap required to place the surgical guide;
  • Do not present a mouth opening of at least 12mm required for the proper of the guided surgical kit together with the surgical guide;
  • Do not present a band of keratinized tissue favorable for maintaining peri-implant health.
  • Present motor difficulties that compromise adequate oral hygiene.

Trial locations and contacts

1 site in 1 country.

Brazil1 site
  • Faculty of Dentistry of the Federal University of Goias

    Goiânia, Goiás

Other trials in Brazil

About this study

Official title: Clinical Performance of Dental Implants With Hydrophilic or Hydrophobic Surfaces in Single Posterior Edentulous Spaces: a Randomized Clinical Trial

The aim of the study is to compare longitudinally the clinical performance of dental implants with different surfaces placed in single tooth gaps at the posterior maxilla and mandible of adults. It is a randomized clinical trial, in which participants will be randomly allocated to two groups: test group (implants with hydrophilic surface) and control group (implants with hydrophobic surface). The null hypothesis is that the implant stability quotient of hydrophilic and hydrophobic dental implants show a similar progression after placement in posterior tooth gaps.

Conditions
Tooth Loss
Being tested
Hydrophilic surface implants, Hydrophobic surface implants
Keywords
single tooth gap, missing tooth
Medical subject headings
Tooth Loss, Anodontia

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Hydrophilic surface implantsDevice

    Also called Neodent Helix Grand Morse® Acqua

    A dental implant with hydrophilic surface will be placed and restored in single-tooh gaps of the posterior region of the mandible or maxilla.

  • Hydrophobic surface implantsDevice

    Also called Neodent Helix Grand Morse® Neoporos

    A dental implant with hydrophobic surface will be placed and restored in single-tooh gaps of the posterior region of the mandible or maxilla.

Study groups in NCT04605016
Study groupRoleWhat they receive
Hydrophilic surface implantsExperimentalNot described
Receives: Device: Hydrophilic surface implants
Hydrophobic surface implantsActive comparatorNot described
Receives: Device: Hydrophobic surface implants

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change of implant stability

    Implant stability was set as the primary outcome. The implant stability quotient (ISQ) will be measured using a portable device called Osstell ISQ (Osstell Mentor, Integration Diagnostics, Göteborg, Sweden).

    Measured: 10 time-points will be considered and divided in two phases: surgical and prosthetic. The last measure will occur 1 year after the placement of the definitive implant restoration.

Secondary outcomes (3)
  1. Implant success

    Each implant will be assessed according to the health scale of the International Congress of Oral Implantologists (ICOI-Pisa health scale). After clinical assessment, each implant will be classified as 'success', 'satisfactory survival', 'compromised survival' or 'failure'.

    Measured: Assessed at the 12-month follow-up visit.

  2. Periimplant bone level

    Periapical radiographs will be obtained and the periimplant bone level will be measured and compared longitudinally.

    Measured: Radiographs will be obtained at 4 time points: immediately after implant placement, at the session of the provisional prosthesis installation, and at the 6 and 12-month follow-up visits after the delivery of the definitive prosthesis.

  3. Condition of the periimplant soft tissues

    The following parameters will be assessed clinically: presence/absence of bleeding on probing, probing depth, and presence/absence suppuration.

    Measured: 15-days, 6- and 12-month follow-up visits after delivery of the definitive prosthesis.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted27 Oct 2020
  2. Study start1 Apr 2021
  3. Primary completion11 Sep 2023 (estimated)
  4. Study completion30 Dec 2023 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Triple blind
Who is masked
Participant, Investigator, Outcomes assessor
Enrolment
44 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04605016
Sponsor's protocol ID
PI04791-2020
Status last verified
May 2023
First submitted
15 Oct 2020
Last updated
10 May 2023
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing Hydrophilic surface implants and Hydrophobic surface implants in people with Tooth Loss, run by Universidade Federal de Goias at 1 site in Brazil.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 10 May 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Brazil. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change of implant stability (time frame: 10 time-points will be considered and divided in two phases: surgical and prosthetic. The last measure will occur 1 year after the placement of the definitive implant restoration.). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 10 May 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in